Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Utilisation du ZArzio® en Post-Autogreffe de Cellules Souches périphériques Des Patients Atteints de Lymphome ou Myélome (in French)

NCT03323541 is registered in ClinicalTrials.gov with University Hospital, Brest as lead sponsor.

NCT NCT03323541
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03323541 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Utilisation du ZArzio® en Post-Autogreffe de Cellules Souches périphériques Des Patients Atteints de Lymphome ou Myélome (in French)
Lead sponsor
University Hospital, Brest
Phase
Observational
Overall status
Completed
Start date
November 3, 2016
Completion date
December 31, 2016
Enrollment
62 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hodgkin lymphoma, multiple myeloma, non-hodgkin lymphoma